liquaemin
Noun: A polysaccharide substance, specifically the anticoagulant drug heparin, that is produced in certain cells (basophils) found in tissues like the lungs and liver. Its primary function is to inhibit thrombin, a key enzyme in the blood clotting process. It is used medically to prevent and treat thrombosis (blood clots) and as an anticoagulant during heart surgery.
This is a technical, proprietary term used primarily in medical and pharmaceutical contexts. It refers to a specific preparation of the drug heparin. - The surgeon administered Liquaemin to prevent clot formation during the procedure. - Liquaemin, an anticoagulant, is essential in the management of deep vein thrombosis.
- As a proper noun/trade name: "Liquaemin" is a brand name. In formal medical writing, the generic name "heparin" is often preferred, but the trade name may be specified.
- The study compared the effects of standard heparin with those of Liquaemin.
- Heparin (n): The generic, non-proprietary name for the anticoagulant drug.
- Anticoagulant (n): A broader category of substances that prevent blood coagulation; heparin/Liquaemin is one type.
- Polysaccharide (n): A type of carbohydrate; describes the chemical class of heparin.
- Heparin (primary synonym, generic term)
- Anticoagulant (broader category synonym)
This word has a single, highly specific meaning in the domain of medicine and pharmacology. It does not have common idiomatic or phrasal verb uses due to its nature as a technical trade name.
- a polysaccharide produced in basophils (especially in the lung and liver) and that inhibits the activity of thrombin in coagulation of the blood; it (trade names Lipo-Hepin and Liquaemin) is used as an anticoagulant in the treatment of thrombosis and in heart surgery